KELSEY COFFRAN: Open Payments
NPI 1265005532 · THORNTON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$991 in 20 payments from 14 companies in 2025. Trend: 2023 $2,703 · 2024 $842 · 2025 $991
Food & beverage: $811Education: $180
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 2 | $228 |
| GENZYME CORPORATION | 4 | $223 |
| Boston Scientific Corporation | 2 | $143 |
| Janssen Biotech, Inc. | 2 | $128 |
| SANOFI-AVENTIS U.S. LLC | 1 | $80 |
| UCB, Inc. | 1 | $36 |
| Novo Nordisk Inc | 1 | $24 |
| LNHC, Inc | 1 | $20 |
| ABBVIE INC. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
Products named: DUPIXENT, NEMLUVIO, WaveWriter Alpha Prime 16, TREMFYA, Bimzelx, Wegovy, ZELSUVMI, SKYRIZI.
Industry payments across CO — which companies pay providers there.
